Imvax is a biotechnology company which licenses Jefferson systemic cancer immunotherapy technology. Founded by D. Craig Hooper in 2015, Imvax is headquartered in Philadelphia.
FOUNDED:
2015
INDUSTRY:
Pharmaceutical, Therapeutics
FOUNDERS:
D. Craig Hooper
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
